Stocks-IMGN-ImmunoGen Inc

IMGN ImmunoGen Inc

31.23 0 (0%)
Markt geslotenVertraagde koersen door NASDAQ, in USD
Handelen

ImmunoGen Inc prijs

6.59% Afgelopen week
Created with Highcharts 4.2.7 /Highstock 4.2.7
Marktkapitalisatie
8.72B
Dagbereik
31.17
-
31.19
52W Bereik
3.60
-
31.19
Volume (3M)
8.92M
Prijs-Winstverhouding
-104.24
Inkomsten
287.61M

ImmunoGen Inc Laatste nieuws

Bekijk alle
Vastgezet bericht
Cancer Treatment Stocks
Verenigd Koninkrijk
Novartis to acquire cancer-focused MorphoSys for $2.9 billion. 💊 Drugmaker $NVS (Novartis ADR) said it will acquire $MOR.DE (MorphoSys), a developer of cancer treatments, for €2.7 billion, adding a promising rare bone-marrow cancer treatment candidate to its portfolio. German biotech firm's shares... Meer weergeven Vertalen
Like ReactieDelen
Toon meer opmerkingen2 van 3
null
.
Top Discussies
Iurii Drabik
Bewerkt
[UPDATED] The Top 10 Gainers in Stocks on eToro in 2023! Not much surprise, there are no big names in the list, rather much more volatile stocks. Let’s list them: 1. $CVNA (Carvana Co) (+1040%) 2. $AAOI (Applied Optoelectronics Inc) (+928%) 3. $MARA (Marathon Digital Holdings Inc.) (+591%) 4. $AMAM... Meer weergeven Vertalen
Like ReactieDelen
Toon meer opmerkingen2 van 4
1 reactie
1 reactie
null
.
Cancer Treatment Stocks
Dear Investors, Here is your monthly update for November 2023 ✨ November was a very positive month for equities and crypto markets. The US Federal Reserves left interest rates unchanged, signalling no more rate hikes. Additionally, a key inflation number was 0.1% below the consensus forecast. The... Meer weergeven Vertalen
Lorenzo Riccio
Like ReactieDelen
null
.
Andrea Antico
Bewerkt
Salesforce ($CRM (Salesforce Inc)) provided a "beat and raise" report for Q3 Snowflake ($SNOW (Snowflake Inc.)) reported upbeat Q3 earnings and revenue and increased its product revenue guidance for FY24 Ford ($F (Ford Motor Co)) said its new U.S. labor agreement with the United Auto Workers... Meer weergeven Vertalen
Tayfur Sener
$IMGN (ImmunoGen Inc) $ABBV (AbbVie Inc) Might be a good chance to short both, Abbvie will be diluted in value if they do buyout Immunogen for $10B, the news is pretty much priced in but will wait to see what direction the trading goes today. Crazy gains and shouldnt get too much higher. Vertalen
Like ReactieDelen
null
.

IMGN Aankomende evenementen

29
FEB
Resultatrapport
Q1 2024
Før markedet åpner

Voorspelling van analisten

Consensus
Hold
Prijsdoel
31.07

ESG: Een nieuwe bron van inzicht

Krijg inzicht in de duurzaamheid van een bedrijf met behulp van ESG-scores (environmental, social en governance).
0
100
39
Zeer laag
Sector 
Gem. 43 
30
Omgeving
42
Sociaal
39
Bestuur

Mensen kochten ook